☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Agomelatine SPC

The Summary of Product Characteristics for agomelatine (Valdoxan®) is now available via the electronic Medicines Compendium (eMC).

As previously discussed, agomelatine is a new class of antidepressant. The SPC gives more details for this drug including known side effects, precautions and interactions.

Action: Clinicians who are considering using this new drug would be wise to review the SPC before starting a treatment.

Share 'Agomelatine SPC' by emailShare 'Agomelatine SPC' on FacebookShare 'Agomelatine SPC' on TwitterShare 'Agomelatine SPC' on LinkedInShare 'Agomelatine SPC' on reddit


No Comments to “Agomelatine SPC”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.